Boardroom Alpha
Meeting calendar
CYH · Annual meeting · Tuesday, May 12, 2026

Community Health Systems Inc

14 nominees · 3 ballot items.

Elect 14 directors; approve, on an advisory basis, the compensation of Named Executive Officers (say-on-pay); and ratify Deloitte & Touche LLP as independent registered public accounting firm for 2026.

Market cap
$454M
1Y TSR
+0.1%
Board grade
C-
Record date
Mar 16, 2026
Filing
DEF 14A
Meeting concluded · May 12, 2026

Follow how the vote landed and what changed on Community Health Systems Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect fourteen (14) directors, each to serve for a one-year term expiring at the 2027 Annual Meeting of Stockholders.

  2. 2

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement.

    More detail

    This non-binding advisory proposal asks stockholders to approve the Company’s disclosed executive compensation for the Named Executive Officers. Management is submitting the advisory vote to gauge stockholder support for its pay framework, which the Compensation Committee designed to align executive incentives with stockholder value through a mix of base salary, at-risk annual cash incentives tied to financial and operational targets, and long-term equity awards (75% of target LTI by share count is performance-based or options). The Compensation Committee emphasizes multiple performance metrics, equity ownership guidelines, clawback provisions, and peer benchmarking as governance safeguards. The proposal is motivated by the Board’s view that the program supports retention of leadership and the execution of strategic initiatives (including margin improvement, revenue growth, and capital structure actions) while aligning pay with both short- and long-term performance. Management frames the vote as advisory and non-binding but states it will take the voting results into account when setting future compensation. The company reports substantial stockholder engagement and notes prior strong Say-on-Pay support (approximately 97% in 2025), which factors into management’s recommendation. In recommending a “FOR” vote, the Board cites the Compensation Committee’s independent consultant, the multi-metric design of incentives, and recent pay-for-performance outcomes (e.g., earned payouts tied to 2025 performance) as reasons shareholders should endorse the disclosed compensation. The proposal’s primary governance risk is its advisory nature — it does not change compensation contractually — but a significant negative vote would prompt the Committee to review program elements and stockholder concerns. Overall, for an analyst assessing governance, the proposal signals a conventional U.S. public-company approach to executive pay with active committee oversight, structured incentives, and stated responsiveness to investor feedback.

  3. 3

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit and Compliance Committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Director elections

Nominees on the ballot14

Independent
Tenure on this board
4.2 yrs
Also a director at
First Merchants Corp (FRME)
Independent
Tenure on this board
8.6 yrs
Also a director at
Crane Nxt Co (CXT)Aebi Schmidt Holding AG (AEBI)
Independent
Tenure on this board
21.6 yrs
Also a director at
NONE
Ownership

Top institutional holders10

Latest 13F quarter
1CastleKnight Management LP9.0%12,667,586$37M
2Apollo Management Holdings, L.P.8.2%11,489,316$34M
3Eversept Partners, LP6.2%8,677,281$26M
4NOMURA HOLDINGS INC4.9%6,885,009$20M
5VANGUARD CAPITAL MANAGEMENT LLC3.8%5,375,503$16M
6BlackRock, Inc.3.3%4,605,212$14M
7BlackRock, Inc.3.0%4,217,409$12M
8WHITEBOX ADVISORS LLC2.2%3,127,884$9M
9TWO SIGMA INVESTMENTS, LP2.1%3,000,406$9M
10VANGUARD PORTFOLIO MANAGEMENT LLC2.1%2,993,496$9M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Community Health Systems Inc 2026 annual meeting?
Community Health Systems Inc (CYH) holds its 2026 annual shareholder meeting on Tuesday, May 12, 2026.
What is the record date for the Community Health Systems Inc 2026 meeting?
The record date for the Community Health Systems Inc 2026 meeting is Monday, March 16, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Community Health Systems Inc's 2026 meeting?
The board is presenting 14 director nominees at the Community Health Systems Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Community Health Systems Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Community Health Systems Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer